A Study of Correlation between Type 2 Diabetes Mellitus and Glycosylated Haemoglobin in a Tertiary Care Centre


Devangana M. Rajyaguru
Anupama R. Kolte
Preeti S. Bajaj


Background: Diabetes is a silent killer. Looking at the alarming presence of diabetes and its morbidity and mortality in India, we need to diagnose this metabolic disorder accurately and at the earliest. We have carried out this study to determine correlation of fasting blood glucose, post meal blood glucose and glycosylated haemoglobin in type 2 Diabetes Mellitus and to find the cut off value of glycosylated haemoglobin to diagnose type 2 diabetes mellitus. Materials and Methods: A cross sectional study was carried out among 298 cases of type 2 Diabetes Mellitus attending a tertiary care centre in Maharashtra during August 2018 to August 2020. Results and Conclusions: Majority were males and in the age group of 41 to 50 years. Fasting Blood Glucose (FBS) and Postprandial Blood Glucose (PPBS) are strongly correlated to Glycosylated Haemoglobin (HbA1c). Association between FBS and PPBS is statistically significant. Correlation of PPBS and HbA1c is stronger than that of FBS and HbA1c. Cut off level of HbA1c is higher in the study subjects in comparison to standard cut off value of 6.5%.


How to Cite
Rajyaguru, D. M. ., Kolte, A. R., & Bajaj, P. S. . (2022). A Study of Correlation between Type 2 Diabetes Mellitus and Glycosylated Haemoglobin in a Tertiary Care Centre. MVP Journal of Medical Sciences, 157–162. https://doi.org/10.18311/mvpjms/2021/v8i2/314


  1. Powers AC, Nisvender KD, Molina CE. Diabetes Mellitus: Diagnosis, classification and pathophysiology. Jameson LJ, Kasper DL, Longo DL, Fausi AS, Hauser SL, Loscalzo J. (eds.) Harrisons Principles of Internal Medicine. 20th ed. New York: McGraw Hill Education; 2018. p. 2850–9.
  2. World Health Organization. Diabetes key facts. 2020. https://www.who.int/news-room/factsheets/detail/diabetes
  3. American Diabetes Association. Diabetes. 2020. https://www.diabetes.org/a1c/diagnosis
  4. Ghazanfarii Z, Haghdoost AA, Alizadeh SM, Atapour J, Zolala F. A comparison of HbA1c and Fasting Blood Sugar tests in general population. Int J Prev Med. 2010; 1(3):187– 94.
  5. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in diagnosis and prognosis of diabetic patients. Biomarker Insights. 2016: 11:95–104. PMid: 27398023 PMCid: PMC4933534. https://doi.org/10.4137/BMI.S38440 DOI: https://doi.org/10.4137/BMI.S38440
  6. Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ. Joslins Diabetes Mellitus. 14th ed. New Delhi: Wolters Kluwer health and Williams and Wilkins; 2005, p. 857.
  7. KC Shiva R. Diabetes Mellitus and glycosylated haemoglobin A1c. Nep Med J. 2018; 2:112–7. https://doi.org/10.3126/nmj.v1i2.21744 DOI: https://doi.org/10.3126/nmj.v1i2.21744
  8. Nordstrom A, Jenny H, Olsson T, Paul W. Franks PW, Nordstrom P. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. JCEM. 2016; 101(10):3740–6. https://doi.org/10.1210/jc.2016-1915 DOI: https://doi.org/10.1210/jc.2016-1915
  9. Mohammadi A, Esmaeili N. Diabetes control and its relationship with HbA1c and blood sugar. The Journal of Qazvin University of Med. 2001; (16):23–6.
  10. Farrukh A, Shafique S, Sajjad A, Naeem S. HbA1c levels among Tertiary Health Care patients with type 2 Diabetes. J M H S. 2018; 12(3):1151–3.
  11. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995; 44:968–83. https://doi.org/10.2337/diabetes.44.8.968 DOI: https://doi.org/10.2337/diab.44.8.968
  12. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing Diabetes Mellitus. J Clin Endocrinol Metab. 2008; 93:2447–53. PMid: 18460560. https://doi.org/10.1210/jc.2007-2174 DOI: https://doi.org/10.1210/jc.2007-2174
  13. Weykamp C, Garry John W, Mosca A. A review of the challenge in measuring Haemoglobin A1c. Journal of Diabetes Science and Technology. 2009; 3(3):439–45. PMid: 20144280 PMCid: PMC2769874. https://doi.org/10.1177/193229680900300306 DOI: https://doi.org/10.1177/193229680900300306
  14. Pasupathi P, Manivannan PM, Uma M, Deepa M, Glycatedhaemoglobin (HbA1c) as a stable indicator of type 2 diabetes. Int J Pharm Biomed Res. 2010; 1(2):53–6
  15. Sikaris K. The correlation of Haemoglobin A1c to blood glucose. J Diabetes Sci Technol. 2009; 3(3):429–38. PMid: 20144279 PMCid: PMC2769865. https://doi.org/10.1177/193229680900300305 DOI: https://doi.org/10.1177/193229680900300305
  16. Swetha NK. Comparison of Fasting Blood Glucose and Post Prandial Blood Glucose with HbA1c in assessing the glycemiccontrol. International J of Healthcare and Biomedical Research. 2014; 2(3):134–9.
  17. Ketema EB, Kibret ET. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and metaanalysis. Ketema and Kibret Archives of Public Health. 2015; 73:43. PMid: 26413295 PMCid: PMC4582842. https://doi.org/10.1186/s13690-015-0088-6 DOI: https://doi.org/10.1186/s13690-015-0088-6
  18. Rosediani M, Azidah AK, Mafauzy M. Correlation between Fasting Plasma Glucose, Post Prandial Glucose and Glycated Haemoglobin and Fructosamine. Med J Malaysia. 2006; 61(1):67–71.
  19. Dubey A, Hisalkar PJ, Mallik N. Correlation between HbA1c and blood sugar levels: Can FBS or PPBS replace HbA1c for monitoring glycemic control in its absence. GJRA. 2019; 8(2):120–2.
  20. Rajbhandari PMS, Gyawali P, Mahato RV, Chaudhary D, et al. A cross-sectional prospective study of Glycated Hemoglobin (Hba1c) and Fasting Blood Glucose (FBG) level in both diabetic and non-diabetic patients in context to Nepalese General Population. Mathews J Diabetes Obes. 2017; 2(2):007.
  21. Dave M, Gupta AK, Patel P, Heernath. Correlation between Fasting Blood Sugar level, HbA1C level and serum lipid levels in type 2 Diabetes Mellitus patients. International Journal of Contemporary Medical Research. 2019; 6(7):G26–9. https://doi.org/10.21276/ijcmr.2019.6.7.13 DOI: https://doi.org/10.21276/ijcmr.2019.6.7.13
  22. Gonen B, Rubenstein AH, Rochman H, Tancga SP, Horwitz DL. Glycosylated haemoglobin: an indicator of the metabolic control of diabetic patients. Lancet. 1977; 2:734–70. https://doi.org/10.1016/S0140-6736(77)90237-9 DOI: https://doi.org/10.1016/S0140-6736(77)90237-9
  23. Cavagnalli G, Comerlato J, Comerlato C, Renz PB, Gross JL, Camargo JL. HbA1c measurement for the diagnosis of diabetes: Is it enough? Diabet Med. 2011; 28:31–5. PMid: 21210540. https://doi.org/10.1111/j.1464-5491.2010.03159.x DOI: https://doi.org/10.1111/j.1464-5491.2010.03159.x
  24. Radhakrishna, P, Vinod, K, Sujiv, A, Swaminathan, R. Comparison of Hemoglobin A1c with fasting and 2-h plasma glucose tests for diagnosis of diabetes and prediabetes among high-risk South Indians. Indian Journal of Endocrinology and Metabolism. 2018; 22(1):50. Mid: 29535937 PMCid: PMC5838911. https://doi.org/10.4103/ijem.IJEM_254_17 DOI: https://doi.org/10.4103/ijem.IJEM_254_17